XML 106 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Deficit - USD ($)
Preferred stock
Ordinary Shares
Class A
Ordinary Shares
Class B
Additional Paid-in Capital
Accumulated Deficit
Total
Beginning Balance at Mar. 10, 2022
Beginning Balance (in Shares) at Mar. 10, 2022      
Accretion of redeemable ordinary shares to redemption value          
Founder shares issued to initial shareholder $ 144 24,856 25,000
Founder shares issued to initial shareholder (in Shares) 1,437,500      
Net income (loss) (66,302) (66,302)
Ending Balance at Dec. 31, 2022 $ 144 24,856 (66,302) (41,302)
Ending Balance (in Shares) at Dec. 31, 2022 1,437,500      
Excess cash received from sales of private placement units over fair value of private placement warrants $ 34 3,368,816 3,368,850
Excess cash received from sales of private placement units over fair value of private placement warrants (in Shares) 343,125      
Issuance of Public Warrants and Public Rights, net off offering costs of $150,780 2,146,425 2,146,425
Accretion of redeemable ordinary shares to redemption value (89,802) (89,802)
Net income (loss) (17,984) (17,984)
Ending Balance at Mar. 31, 2023 $ 34 $ 144 5,450,295 (84,286) 5,366,187
Ending Balance (in Shares) at Mar. 31, 2023 343,125 1,437,500      
Beginning Balance at Dec. 31, 2022 $ 144 24,856 (66,302) (41,302)
Beginning Balance (in Shares) at Dec. 31, 2022 1,437,500      
Excess cash received from sales of private placement units over fair value of private placement warrants $ 34 3,368,816 3,368,850
Excess cash received from sales of private placement units over fair value of private placement warrants (in Shares) 343,125        
Issuance of Public Warrants and Public Rights, net off offering costs of $150,780 2,146,425 2,146,425
Accretion of redeemable ordinary shares to redemption value (5,540,097) (1,878,148) (7,418,245)
Net income (loss) 1,308,097 1,308,097
Ending Balance at Dec. 31, 2023 $ 34 $ 144 (636,353) (636,175)
Ending Balance (in Shares) at Dec. 31, 2023 343,125 1,437,500      
Accretion of redeemable ordinary shares to redemption value (2,553,357) (2,553,357)
Net income (loss) 143,504 143,504
Ending Balance at Mar. 31, 2024 $ 34 $ 144 $ (3,046,206) $ (3,046,028)
Ending Balance (in Shares) at Mar. 31, 2024 343,125 1,437,500